08:00 , Feb 4, 2016 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: δ-4-desaturase sphingolipid 1 (DEGS1)

Cancer INDICATION: Prostate cancer Cell culture studies identified a DEGS1 inhibitor that could help treat prostate cancer. Chemical synthesis and in vitro testing of oxadiazole analogs identified a compound that decreased conversion of the DEGS1 substrate...